Here are relevant reports on : clinical-decision-support-systems-market
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Global Forecast to 2021
The global antinuclear antibody test market size is projected to grow at a CAGR of 12.4%. This market is segmented based on products, diseases, techniques, end users, and regions. On the basis of products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global ANA testing market, primarily due to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Clinical Workflow Solutions Market by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region - Global Forecast to 2025
The global clinical workflow solutions market growth is primed to transition from USD 9.1 billion in 2020 to USD 18.1 billion by 2025, showcasing a strong CAGR of 14.8%. Growth in this market is driven by the implementation of government initiatives supporting the adoption of HCIT solutions, advantages of clinical workflow solutions in enhancing patient care and safety, increasing patient volume due to the COVID-19 pandemic, growing adoption of EHRs and other HCIT solutions, and the rising need to curtail healthcare costs.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Management Decision Market by Offering, Vertical (BFSI, Retail & Consumer Goods, Telecom, IT & ITeS, Healthcare & Lifesciences, Manufacturing, Government, Transportation & Logistics, Energy & Utilities), Application and Region - Global Forecast to 2028
The Management Decision market size is projected to reach USD 11.4 billion by 2028, at a CAGR of 13.0% during the forecast period. The management decision market comprises major providers, such as IBM (US), FICO (US), SAS (US), Oracle (US), Pegasystems (US), TIBCO Software (US), Sapiens International Corporation (Israel), Experian (Ireland), Equifax (US), Actico (Germany), Parmenides (Germany), Decision Management Solutions (US), OpenRules (US), Sparkling Logic (US), Scorto (Netherland), RapidGen (UK), Progress (US), InRule (US), CRIF (Italy), Decisions (US), Enova Decisions (US), FlexRule (Australia), Rulex (US), Seon (UK), and Decisimo (UK). To increase their market share in the Management Decision industry, these competitors have used a variety of growth methods, including partnerships, agreements, collaborations, new product releases, product enhancements, and acquisitions.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Banking Hardware Maintenance, Software Support and Helpdesk Support Services Market by Key Trends and Statistics, Regional Perspective, Market Size Estimation, Vendor Insights, Partnership Opportunities and Competitive Landscape - Global Forecast to 2021
Global market size for maintenance and support services for banking hardware devices and equipment is expected to grow from USD 8.4 billion in 2018 to USD 10.4 billion by 2021 at the Compound Annual Growth Rate (CAGR) of 7.5%. Automated Teller Machine (ATM) Maintenance & Operational Support Services are the largest market contributors. North America leads the market followed by European Union; while Asia Pacific Is the fastest growing geography. The ATM install base market is highly consolidated with top 4 players that contribute64% to the overall market. Wincor Nixdorf (US), Diebold Nixdorf (US), NCR (US), and Oki Electric (Japan) are the leaders in this market space owing to the strong brand recognition, healthy financial position, and high R&D investments among others.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Medical Device Engineering Market by Service Type (Product Support & Maintenance, Prototyping, Electronic Engineering, Connectivity and Mobility Services), Device Type (Patient Monitoring, & Life Support, Medical Lasers, IVD) - Global Forecast to 2029
The global medical device engineering market, valued at US$8.2 billion in 2023, stood at US$9.0 billion in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.7 billion by the end of the period. The growth of the market is driven by a host of factors: rapid advancements in medical technology, an increased incidence of chronic diseases, and stringent regulatory requirements.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare IT Market by Solution [Clinical (EHR, PACs & VNA, Telehealth, CDSS, Medical Image), Nonclinical (Clinical Analytics, RCM, Interoperability), Service (Claim, Billing)], End User [Hospital, ASC, Pharmacy, Payer]-Forecast to 2030
The Asia Pacific Healthcare IT market, valued at USD 68.96 billion in 2024, stood at USD 80.69 billion in 2025 and is projected to advance at a resilient CAGR of 17.6% from 2025 to 2030, culminating in a forecasted valuation of USD 181.30 billion by the end of the period. The Asia Pacific healthcare IT market is growing steadily, driven by increasing healthcare digitalization, rising patient volumes, government initiatives to adopt health IT, and expanding use of cloud, AI, and analytics in the region.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
